Avanza Fonder
WST icon

Avanza Fonder’s West Pharmaceutical WST Stock Holding History

Avanza Fonder’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.22M Hold
5,992
– – 0.04% 273
2026
Q2 		$2.15M Sell
5,992
-1,516
-20% -$463K 0.05% 273
2026
Q1 		$1.88M Hold
7,508
– – 0.05% 276
2025
Q4 		$2.07M Hold
7,508
– – 0.05% 267
2025
Q3 		$1.97M Hold
7,508
– – 0.05% 256
2025
Q2 		$1.64M Hold
7,508
– – 0.05% 280
2025
Q1 		$1.66M Sell
7,508
-285
-4% -$78.5K 0.05% 274
2024
Q4 		$2.55M Buy
+7,793
New +$2.45M 0.08% 208

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Avanza Fonder's WST Position: Q3 2026 in Review

Avanza Fonder held its West Pharmaceutical (WST) position steady in Q3 2026 at 5,992 shares worth $2.22M. The position accounts for 0.04% of the portfolio, ranked #273.

Avanza Fonder first reported a position in WST in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.55M in Q4 2024. 456 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Avanza Fonder held 5,992 shares of West Pharmaceutical worth $2.22M as of Q3 2026.
  • Avanza Fonder left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up 0.04% of Avanza Fonder's portfolio in Q3 2026, its #273 holding.
  • Avanza Fonder first reported a position in West Pharmaceutical in Q4 2024 and has held it in 8 quarters since.
  • Avanza Fonder's West Pharmaceutical position peaked at $2.55M in Q4 2024.
  • 456 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.